Vernix caseosa is a cream-like substance secreted by the skin of a fetus in the womb. It is composed of fatty white or yellowish-white sebum, lanugo (fetal hair), and cellular debris from epidermal skin cells. It is thought to provide protection from the amniotic fluid, and promotes the transition to life outside the womb by increasing hydration of the skin, regulating skin temperature, providing antimicrobial protection, and aiding in desquamation of the fetal skin. Vernix caseosa is most prominent around the time of birth, especially in premature infants. It can be observed covering the face or scalp or increases of the body, like the neck, underarms, and hands. As babies age, it will start to disappear, typically after day 2 to 5 after birth. It has been described as appearing cheese-like due to its composition, but may vary in texture, from a thick paste to a slimy material. It can also vary in color from white to yellow-brown, though bloodstains may give it a reddish hue. There are several areas of research into the role and function of vernix caseosa, including its role in preventing UVC-induced neonatal skin damage, as well as its use in alleviating symptoms of certain dermatological conditions. There have been several studies that suggest vernix caseosa has antimicrobial properties that help protect the skin from infection and inflammation. The primary role of vernix caseosa is to ensure neonatal skin hydration, regulation of temperature, and a protective function to baby from environmental hazards, particularly ultraviolet (UV) radiation. Its role in promoting desquamation of the fetal skin has been the subject of much research as well. Additionally, there is evidence that suggests vernix caseosa may be effective in treating skin disorder and diseases, such as eczema, psoriasis, and atopic dermatitis. All in all, vernix caseosa plays a vital role in providing the newborn with optimal physiological and protective advantages as they transition from life in the womb to life outside the womb.
Title : Personalized and precision dermatology through the view of biodesign-inspired translational & data-driven applications: Revolutionary skin treatments for every concern in clinical dermatology integrating skin care experts and consumers
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Paraneoplastic Autoimmune Multiorgan Syndrome or PAMS: Paraneoplastic pemphigus revisited
Sergei A Grando, University of California Irvine, United States
Title : Art, skin, and dermatology: Interdisciplinary perspectives
Dechelette Corinne, La Peau Autrement, France
Title : The next generation of threads: Lifting, volumization, and biostimulation in one powerful triple action
George Sulamanidze, The Clinic of Plastic Surgery and Aesthetic Dermatology, Totalcharm, Georgia
Title : Translating genetic and immune insights into psoriasis management
Ravi M Rathod, Karnataka Medical College and Research Institute, India
Title : Assessing efficacy and safety of hair growth products in a clinical design using qualitative and quantitative techniques
Nalini Kaul, Princeton Consumer Research, Canada
Title : Refining craft: Expert injectables techniques based on cutting-edge anatomy
Syed Nazim Hussain, DermaTrico, India
Title : Comparative efficacy of omalizumab and dupilumab in children with Chronic Spontaneous Urticaria (CSU): A retrospective cohort analysis
Molynna Nguyen, University of Toledo, United States
Title : Lymphoproliferative diseases in the practice of a dermatologist
Sergeeva Irina, Novosibirsk State University, Russian Federation
Title : The magic window timing for perimenopausal women
Diane Madfes, Madfes Aesthetic Medical Center, United States